R Bonan

1.3k total citations
45 papers, 976 citations indexed

About

R Bonan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R Bonan has authored 45 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R Bonan's work include Coronary Interventions and Diagnostics (18 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (7 papers). R Bonan is often cited by papers focused on Coronary Interventions and Diagnostics (18 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (7 papers). R Bonan collaborates with scholars based in Canada, United States and United Kingdom. R Bonan's co-authors include Pierre Théroux, David D. Waters, Jacques Lespérance, James J. Ferguson, John Strony, Del D. Miller, J Szlachcic, V V Kakkar, J T Willerson and Ihor Dyrda and has published in prestigious journals such as Circulation, Kidney International and European Heart Journal.

In The Last Decade

R Bonan

44 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Bonan Canada 14 674 511 292 175 162 45 976
Harold E. Aldridge Canada 17 938 1.4× 757 1.5× 273 0.9× 270 1.5× 97 0.6× 43 1.2k
Petra Hoppmann Germany 22 911 1.4× 574 1.1× 147 0.5× 223 1.3× 133 0.8× 66 1.4k
Craig E. Hjemdahl-Monsen United States 10 872 1.3× 903 1.8× 832 2.8× 301 1.7× 63 0.4× 12 1.4k
U Kaufmann Switzerland 21 1.1k 1.6× 1.1k 2.1× 438 1.5× 390 2.2× 95 0.6× 68 1.6k
Dennis Wahr United States 14 965 1.4× 605 1.2× 448 1.5× 281 1.6× 80 0.5× 21 1.3k
Aleksander Araszkiewicz Poland 18 840 1.2× 642 1.3× 240 0.8× 474 2.7× 175 1.1× 132 1.3k
Giovanni Schiavoni Italy 20 1.0k 1.5× 1.1k 2.1× 434 1.5× 445 2.5× 191 1.2× 58 1.5k
Paolo Sganzerla Italy 17 630 0.9× 313 0.6× 134 0.5× 293 1.7× 54 0.3× 57 1.0k
Marek Krzanowski Poland 14 240 0.4× 400 0.8× 101 0.3× 239 1.4× 201 1.2× 37 666
H. Köstering Germany 7 787 1.2× 467 0.9× 566 1.9× 96 0.5× 80 0.5× 17 988

Countries citing papers authored by R Bonan

Since Specialization
Citations

This map shows the geographic impact of R Bonan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Bonan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Bonan more than expected).

Fields of papers citing papers by R Bonan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Bonan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Bonan. The network helps show where R Bonan may publish in the future.

Co-authorship network of co-authors of R Bonan

This figure shows the co-authorship network connecting the top 25 collaborators of R Bonan. A scholar is included among the top collaborators of R Bonan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Bonan. R Bonan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asgar, Anita, Paul Khairy, Lisa Bernard, et al.. (2014). Real-World Cost Effectiveness Of The Mitraclip For The Treatment Of High-Risk Mitral Regurgitation. Value in Health. 17(3). A3–A3. 1 indexed citations
2.
Franceschi, Frédéric, R Bonan, Paul Khairy, et al.. (2011). Histopathological effects and evolution of transvenous  -radiation applications in right and left atria: an animal study. EP Europace. 14(5). 745–751. 2 indexed citations
3.
Grube, E., Ulrich Gerckens, Gerhard Schüler, et al.. (2008). Experience with CoreValve aortic valve replacement in patients for surgical aortic valve replacement. Cardiovascular revascularization medicine. 9(2). 111–111. 2 indexed citations
4.
Fajadet, Jean, et al.. (2007). Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.. PubMed. 55(1). 1–18. 67 indexed citations
5.
Berry, Colin, et al.. (2007). Importance of collateral circulation in coronary heart disease. European Heart Journal. 28(3). 278–291. 99 indexed citations
6.
Misra, Sanjay, et al.. (2006). BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney International. 70(11). 2006–2013. 30 indexed citations
7.
Coen, V., Patrick W. Serruys, W. Sauerwein, et al.. (2003). Reno, a European postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practice. International Journal of Radiation Oncology*Biology*Physics. 55(4). 1019–1026. 35 indexed citations
8.
Eeckhout, E., E. Benedetti, Philippe Coucke, et al.. (2001). Treatment of in-stent-restenosis by combining cutting balloon angioplasty and vascular brachytherapy : a report from the RENO registry. European Heart Journal. 3 indexed citations
9.
Serruys, P.W., A. Colombo, Éric Eeckhout, et al.. (2001). Clinical application of intracoronary beta brachytherapy using Sr/Y90 source trains : a european surveillance registry with the Novoste Betacath system.. European Heart Journal. 1 indexed citations
10.
Seabra-Gomes, R, Harry Suryapranata, William Wijns, et al.. (2000). Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. PubMed. 3(4). 215–225. 46 indexed citations
11.
Bonan, R, et al.. (1999). Geographic miss: what is it?. PubMed. 11(12). 749–56. 8 indexed citations
12.
Bonan, R. (1996). Local Drug Delivery for the Treatment of Thrombus and Restenosis.. PubMed. 8(8). 399–402. 1 indexed citations
13.
Pande, Arun K., et al.. (1996). Coronary Angioplasty in the Treatment of Post-Cardiac Transplant Coronary Artery Disease.. PubMed. 8(6). 252–256. 2 indexed citations
14.
Feuvre, Claude Le, R Bonan, Antonio Serra, et al.. (1995). Mitral valve rupture following percutaneous mitral commissurotomy: existence of predictive factors. European Heart Journal. 16(1). 43–48. 8 indexed citations
15.
Lefèvre, Thierry, Anne Bernard, Michel Bertrand, et al.. (1994). [Electron microscopic comparison of the antithrombotic potential of 2 low osmolality iodine contrast media in percutaneous transluminal coronary angioplasty].. PubMed. 87(2). 225–33. 8 indexed citations
16.
Topol, Eric J., R Bonan, D E Jewitt, et al.. (1993). Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.. Circulation. 87(5). 1622–1629. 172 indexed citations
17.
Bonan, R, Thierry Lefèvre, Ángel Cequier, et al.. (1991). [Percutaneous mitral valvuloplasty. An analysis of the immediate results].. PubMed. 44(3). 174–83. 1 indexed citations
18.
DeWall, Richard A., et al.. (1984). Factors influencing thromboembolic complications in Omniscience cardiac valve patients. European Heart Journal. 5(suppl D). 53–57. 7 indexed citations
19.
Chaitman, Bernard, R Bonan, Guy Lepage, et al.. (1979). Hemodynamic evaluation of the Carpentier-Edwards porcine xenograft.. Circulation. 60(5). 1170–1182. 45 indexed citations
20.
Bonan, R, et al.. (1959). [Galloping tuberculosis in a case of Hodgkin's disease treated with prednisone].. PubMed. 50(17). 589–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026